Oraya Therapeutics

About:

Oraya Therapeutics develops non-invasive robotically-controlled treatments for inflammatory and neovascular diseases of the eye.

Website: http://www.orayainc.com

Twitter/X: zeiss_group

Top Investors: Scale Venture Partners, Domain Associates, Essex Woodlands Healthcare Partners, Synergy Life Science Partner

Description:

Oraya Therapeutics is currently testing its first application of the IRay system. Oraya Therapeutics develops noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye.

Total Funding Amount:

$97.3M

Headquarters Location:

Newark, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)orayainc.com

Founders:

Michael Gertner

Number of Employees:

51-100

Last Funding Date:

2014-08-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai